Canada markets close in 6 hours 12 minutes
  • S&P/TSX

    20,236.89
    -384.50 (-1.86%)
     
  • S&P 500

    4,315.91
    -82.03 (-1.87%)
     
  • DOW

    33,724.61
    -540.76 (-1.58%)
     
  • CAD/USD

    0.7912
    -0.0036 (-0.46%)
     
  • CRUDE OIL

    83.64
    -1.50 (-1.76%)
     
  • BTC-CAD

    42,695.39
    -2,391.22 (-5.30%)
     
  • CMC Crypto 200

    771.57
    -39.03 (-4.82%)
     
  • GOLD FUTURES

    1,832.70
    +0.90 (+0.05%)
     
  • RUSSELL 2000

    1,948.71
    -39.21 (-1.97%)
     
  • 10-Yr Bond

    1.7190
    -0.0280 (-1.60%)
     
  • NASDAQ

    13,472.26
    -296.66 (-2.15%)
     
  • VOLATILITY

    33.52
    +4.67 (+16.19%)
     
  • FTSE

    7,356.27
    -137.86 (-1.84%)
     
  • NIKKEI 225

    27,588.37
    +66.11 (+0.24%)
     
  • CAD/EUR

    0.7001
    -0.0003 (-0.04%)
     

Bausch + Lomb Files for U.S. Initial Public Offering

  • Oops!
    Something went wrong.
    Please try again later.
·1 min read
In this article:
  • Oops!
    Something went wrong.
    Please try again later.
  • BHC

(Bloomberg) -- Bausch + Lomb Corp., the maker of contact lenses and eye-care products, filed to go public in the U.S. and Canada through an initial public offering.

Most Read from Bloomberg

The unit of Bausch Health Co. said in a filing Thursday it would seek to raise $100 million, a placeholder amount that’ll likely change. Morgan Stanley and Goldman Sachs Group Inc. are advising on the listing.

The listing will involve only existing shares and no new shares will be offered, according to the filing.

Founded in 1853 by John Jacob Bausch and Henry Lomb in Rochester, New York, the optical products maker reported $2.8 billion in revenue in the nine months ended September 2021, up 12% from the same period a year ago, the document showed. Its net income shrunk to $131 million from $191 million.

Bausch + Lomb is seeking to list shares on both the New York and Toronto Stock Exchanges. It plans to float shares under the symbol BLCO.

(Corrects ticker symbol in last line of article)

Most Read from Bloomberg Businessweek

©2022 Bloomberg L.P.

Our goal is to create a safe and engaging place for users to connect over interests and passions. In order to improve our community experience, we are temporarily suspending article commenting